The prevalence of sleep disturbances among patients with COVID-19

 Due to the importance of sleep disorders and the unknown effects that they may have on the course of the disease in COVID-19 patients, in this study, we aimed to investigate the factors affecting sleep disorders in these patients.

 The present research was a cross-sectional analytical study conducted in Razi Hospital in Rasht. The study population included COVID-19 patients referred to the corona clinic of Razi Hospital for follow-up. Information about age, gender, body mass index (BMI), underlying disease, drugs used, a history of using cigarette and opioids, duration of hospitalization, and type of hospitalization (normal ward or the intensive care unit (ICU) ward) was extracted from patients’ files and recorded in the data collection form. The Petersburg Sleep Quality Index (PSQI) was used to assess sleep disorders. The collected data were entered into SPSS software version 24. The significance level of the tests was considered P < 0.05.

 The mean age of the subjects in this study was 43.79 years. According to the results, 52 people were male (52.5%) and the rest were female. Based on the results, it was found that age (p = 0.540), gender (p = 0.141), BMI (p= 0.464), cigarette use (p = 0.675), opium use (p = 0.757), underlying disease (p = 0.430), drug use (p = 0.327), and duration of hospitalization (p = 0.203) were not significantly associated with sleep disorders.

 According to the findings of this study, sleep in patients with COVID-19 is not associated with age, gender, cigarette use, opium use, underlying disease, duration of hospitalization, and a history of drug use.